Lnc-FTX inhibited hepatocellular carcinoma growth and metastasis by competitively binding to miR-374a and mini-chromosome maintenance complex component 2 (MCM2), which inhibited Wnt/β-catenin signaling and DNA replication. This evidence concerns the gene FTX and hepatocellular carcinoma.